Cellosaurus ARD-EZH2i-R (CVCL_A5RY)
| Cell line name | ARD-EZH2i-R |
|---|---|
| Synonyms | ARD_EZH2i_R; ARD-R |
| Accession | CVCL_A5RY |
| Resource Identification Initiative | To cite this cell line use: ARD-EZH2i-R (RRID:CVCL_A5RY) |
| Comments | Selected for resistance to: ChEBI; CHEBI_167693; 1-isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)-1H-indazole-4-carboxamide (GSK343). Omics: Transcriptomics; RNAseq. Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Cell type: Plasma cell; CL=CL_0000786. |
| Sequence variations |
|
| Disease | Plasma cell myeloma (NCIt: C3242) Multiple myeloma (ORDO: Orphanet_29073) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_XD83 (ARD) |
| Sex of cell | Female |
| Age at sampling | Age unspecified |
| Category | Cancer cell line |
| Publications | PubMed=29045832; DOI=10.1016/j.celrep.2017.09.078; PMCID=PMC5706555 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q107113377 |
| Gene expression databases | GEO; GSM2774138
GEO; GSM2774141 GEO; GSM2774143 GEO; GSM2774146 |
| Entry history | |
| Entry creation | 20-May-2021 |
| Last entry update | 14-Aug-2025 |
| Version number | 8 |